CVE-2015-3957

mediumpriority · track · 18OT risk · elevatedEPSS 0.005 · 45 %ileEURUUS
grimoire priorityP3 · Track
Exploitable?
—
no known exploitation
Likely / severe?
0.54% (45th) EPSS
CVSS 4.6 · medium
Is it mine?
13 products
Check your exposure
Who says so?
5 sources
cnnvd · enisa_euvd · fstec_bdu · cisa_csaf_ot

EPSS · scored 2026-10-22

Hospira LifeCare PCA Infusion System before 7.0 stores private keys and certificates, which has unspecified impact and attack vectors.

01

remediations

Vendor fix, mitigation, or workaround guidance, as published by each source.

No vendor fix yet; a mitigation is available.

  • MitigationLifeCare PCA Infusion Systemcisa_csaf_ot

    Existing PCA Infusion Systems running Version 5.0 can be upgraded to Version 7.0 when it becomes available. Hospira will be retiring older versions of the LifeCare PCA Infusion System, Versions 2 and Versions 3, by the end of the year, 2015.

  • MitigationPlum A+ Infusion Systemcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationPlum A+3 Infusion Systemcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

  • MitigationSymbiq Infusion System,As previously announced by Hospira in 2013, the Symbiq Infusion System was retired by Hospira on May 31, 2015 and will be fully removed from the market by December 2015. According to Hospira, during a recent service visit, the remaining Symbiq Infusion Systems have had Port 20/FTP and Port 23/TELNET closedcisa_csaf_ot

    For additional information about the vulnerabilities and compensating measures, contact Hospira’s technical support at 1-800-241-4002.

02

cvss

Technical severity, 0–10. One row per scoring source.

4.6
010

base score 0–10 · higher = more severe · hover a vector to decode⚠ sources disagree · low–medium · 3.9–4.6

v2.04.6mediumAV:L/AC:L/Au:N/C:P/I:P/A:Pprimary · NVD / NIST USexploitability 3.9 · impact 6.4
v2.04.6mediumAV:L/AC:L/Au:N/C:P/I:P/A:Psecondary · CISA US
v2.04.6mediumAV:L/AC:L/Au:N/C:P/I:P/A:Psecondary · FSTEC (BDU) RU
v2.03.9lowAV:L/AC:L/Au:N/C:P/I:P/A:P/E:Usecondary · CVSS-BT (t0sche)
03

weaknesses

The CWE weakness classes this flaw belongs to.

CWE-255USprimaryCWE-255USCWE-321US
04

affected products (13)

Products and version ranges known to be affected.

05

advisories (2)

Vendor and ecosystem advisories describing this.

  • ICSA-15-125-01BHospira LifeCare PCA Infusion System Vulnerabilities2015-02-05icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

  • ICSA-15-161-01Hospira Plum A+ and Symbiq Infusion Systems Vulnerabilities2015-03-13icsa · cisa_csaf_otUS

    This CSAF advisory was extracted from unstructured data and may contain inaccuracies. If you notice any errors, please reach out to the designated contact at CISA CSAF: central@cisa.dhs.gov

06

also known as (4)

Other names and identifiers for this entity.

07

sources

Which sources assert this record, and when.

cnnvdenisa_euvdfstec_bducisa_csaf_otnvdNVDCVE.orgMITRE
published 2015-07-06modified 2026-06-17
09

references (10)

External citations — patches, advisories, analysis.

scry

Attackers weaponise vulnerabilities like this against internet-exposed services. See what is exposed on your perimeter with a free passive scan.

Free scan